Medical Device Network Isolation

Medical Device Network Isolation (HICP Practice 9.3) requires you to place medical devices on dedicated network segments and strictly control any traffic between those segments and your clinical or administrative networks. Operationally, you must define device network zones, implement allowlisted pathways, and keep evidence that segmentation and access controls work as designed ¹.

Key takeaways:

• Put medical devices on dedicated network segments; do not leave them on flat enterprise networks ¹.
• Control and document every approved connection between device networks and other zones using explicit rules and monitored pathways ¹.
• Maintain proof: network diagrams, firewall/ACL rules, device inventories mapped to segments, and test results that show isolation is effective.

Network isolation is one of the few controls that reduces risk even when medical devices cannot be patched quickly, cannot run endpoint agents, or have fragile operating systems. HICP Practice 9.3 sets a clear expectation: medical devices belong on dedicated network segments, and traffic to and from those segments must be controlled ¹. For a Compliance Officer, CCO, or GRC lead, the hard part is not agreeing with the idea. The hard part is translating it into network decisions that hold up during an audit: what counts as a “medical device network,” how to handle imaging modalities that need to talk to PACS, how remote vendor support works without punching holes through segmentation, and how to prove the controls stay in place over time.

This page focuses on requirement-level implementation: scoping, design choices, step-by-step execution, and audit-ready artifacts. It assumes you have multiple stakeholders (biomed/HTM, IT networking, security, clinical ops, and third parties such as device manufacturers or managed service providers). Your goal is a repeatable pattern: every device is inventoried, placed into the right segment, and only permitted to communicate through approved, monitored paths.

Regulatory text

HICP Practice 9.3: “Isolate medical devices on dedicated network segments with controlled access to and from clinical and administrative networks.” ¹

What the operator must do

• Create dedicated network segments for medical devices. “Dedicated” means the segment’s primary purpose is medical devices, not general user endpoints or shared IT infrastructure ¹.
• Control access across network boundaries. Any communication between the medical device segment and clinical/admin networks must be explicitly governed, typically by firewall rules, ACLs, and tightly managed gateways ¹.
• Be able to show control is deliberate and maintained. Auditors will expect evidence that segmentation exists, that allowed flows are justified, and that changes follow a managed process.

Plain-English interpretation (what “medical device network isolation requirement” means)

You need to prevent medical devices from sharing the same “blast radius” as user laptops, servers, or administrative systems. Put devices in their own network zones and only allow the minimum traffic required for clinical operation (for example, to an EHR interface engine, PACS, time sync, or update servers). If a device is compromised, segmentation should limit lateral movement. If the enterprise network is compromised, segmentation should limit paths into device networks.

A practical definition that holds up in audits:

• Default deny between zones (medical device zone ↔ other zones).
• Allowlist only the specific source, destination, port, and protocol needed for documented workflows.
• Monitor and review the approved pathways and segmentation drift.

Who it applies to (entity and operational context)

Applies to:

• Healthcare organizations that operate medical devices connected to networks (hospitals, health systems, ambulatory surgery centers, clinics with connected imaging, labs, and infusion systems) ¹.
• Health IT vendors that manage, host, or provide network-connected clinical environments (for example, managed network services supporting provider environments, or third parties operating clinical networks) ¹.

Operational contexts where auditors focus:

• Mixed environments where medical devices were historically placed on “any open jack.”
• Mergers/acquisitions with inconsistent VLAN and firewall design.
• Vendor remote access that bypasses segmentation.
• Clinical/biomed-managed subnets that IT/security cannot see or govern.

What you actually need to do (step-by-step)

1) Establish scope and ownership

1. Define “medical device” for networking purposes. Use your internal definition aligned to what biomed/HTM tracks as clinical devices connected to the network.
2. Name accountable owners. Typical split:
   • Biomed/HTM: device inventory, device operational requirements, maintenance windows.
   • Network team: VLANs/VRFs, routing, NAC, firewall implementation.
   • Security: segmentation standards, rule review, monitoring expectations.
   • GRC: requirement mapping, evidence, control testing cadence.

2) Build the minimum viable device segmentation design

1. Choose a zoning model you can operate. Examples:
   • Per-site device VLANs with a shared “medical device firewall” layer.
   • Per-device-category segments (imaging, patient monitoring, lab, building/clinical IoT) if workflows differ.
2. Decide where inter-zone control lives. Most commonly:
   • A firewall between device segments and enterprise networks.
   • ACLs at distribution/core, plus a firewall for north-south control.
3. Define a default traffic stance. Start with “deny by default” and document the exception process for clinical needs.

3) Inventory devices and map them to segments

1. Create a device inventory that networking can act on. Minimum fields:
   • Device name/type, location, MAC/IP, owner (clinical department), manufacturer, support contact, required systems it talks to.
2. Map each device to a target segment. If you cannot place a device yet, log it as an exception with a planned remediation path.

Practical note: inventory quality is where isolation projects fail. If you cannot reliably identify devices, you cannot keep them isolated after changes.

4) Implement dedicated segments and controlled pathways

1. Create the dedicated segments. Build VLANs/VRFs (or equivalent) and routing boundaries.
2. Force medical devices into the right segment. Common mechanisms:
   • Static port assignments for known device closets.
   • NAC profiles for device classes where feasible.
3. Implement controlled access between zones.
   • Build allowlist rules for required communications only.
   • Use explicit source/destination objects (device subnets, interface servers, PACS, EHR integration points).
4. Control vendor remote access.
   • Route all remote support through an approved access method that terminates in a controlled zone (for example, jump host/bastion) rather than direct inbound access to device subnets.
   • Require approvals and logging for sessions.

5) Validate isolation works (control testing you can show)

1. Connectivity validation: confirm clinical workflows function after segmentation.
2. Segmentation validation: demonstrate that a device subnet cannot reach prohibited enterprise resources and that enterprise endpoints cannot initiate unrestricted sessions into the device network.
3. Rule review: validate every allowed rule has a clinical/operational justification and an owner.

6) Operationalize: keep isolation from drifting

1. Change control: any new device or workflow requires a documented request for network placement and firewall rules.
2. Periodic review: review device segments, allowlist rules, and exceptions; retire stale rules tied to decommissioned devices.
3. Monitoring: alert on unexpected traffic crossing device boundaries (for example, new destinations, new protocols, or unusual volumes).

7) Third-party governance (where Daydream fits)

Medical device network isolation depends on third parties: device manufacturers, remote support providers, and managed network/security providers. You need them to disclose network requirements, remote access methods, and support dependencies so your allowlists are tight and auditable. Daydream can centralize third-party due diligence artifacts (network diagrams provided by the manufacturer, support access procedures, subcontractor details, and security attestations), tie them to specific device categories, and track exceptions and review workflows so segmentation decisions remain governed rather than tribal knowledge.

Required evidence and artifacts to retain (audit-ready)

Keep artifacts that prove design, implementation, and ongoing control:

Architecture and design

• Network segmentation diagram(s) showing medical device segments and controlled connection points.
• Written standard for medical device network zoning and default traffic stance.

Inventory and mapping

• Medical device inventory with network identifiers (MAC/IP), owner, and assigned segment.
• Mapping record that shows each device category and its approved communications.

Access control evidence

• Firewall/ACL configurations (export or screenshots) covering:
  • Device segment boundaries
  • Approved inter-zone flows
• Rule documentation: purpose, owner, ticket/change reference, review date.

Testing and validation

• Segmentation test results (connectivity tests and negative tests).
• Implementation sign-offs from network/security and clinical/biomed stakeholders.

Operational governance

• Change management tickets for new segments and rule changes.
• Exception register for devices not yet isolated, including risk acceptance and remediation plan.
• Remote access logs and approvals for third-party support sessions (where applicable).

Common exam/audit questions and hangups

Auditors and assessors tend to drill into the same issues:

• “Show me the dedicated segments.” They want diagrams plus configuration proof that the segments exist and are enforced.
• “What traffic is allowed out of the medical device networks, and why?” Expect scrutiny of broad “any/any” rules, wide destination ranges, or undocumented ports.
• “How do you stop a new device from landing on the wrong VLAN?” If placement relies on manual steps, show the procedure, approvals, and how you detect drift.
• “How is third-party remote access controlled?” They will look for uncontrolled VPNs, shared accounts, or unlogged access paths.

Frequent implementation mistakes (and how to avoid them)

1. Flat VLANs labeled “MEDICAL” with no enforcement. A label is not isolation. Put a control point (firewall/ACL boundary) between device segments and other zones.
2. Overly permissive rules to “make it work.” Start from documented workflows. Add narrow rules, then expand only with justification and owner sign-off.
3. No exception process. Some legacy devices will not tolerate segmentation changes on day one. Track them explicitly, time-box remediation, and require compensating controls.
4. Ignoring east-west device traffic. Some devices talk to peers (for example, modality to workstation). Document these flows and keep them within the smallest zone possible.
5. Shadow IT/biomed networks with no security visibility. Bring device networks into managed monitoring and change control; otherwise, isolation degrades silently.

Enforcement context and risk implications

HICP is a widely referenced set of healthcare cybersecurity practices published by HHS, and Practice 9.3 expresses a clear expectation for segmentation of medical devices ¹. Even without case citations in this source set, the risk logic is straightforward: medical devices often have long lifecycles, constrained patching, and operational constraints. Network isolation becomes a primary control to reduce the impact of malware, credential theft, and lateral movement that can disrupt clinical operations.

Practical 30/60/90-day execution plan

First 30 days (stabilize and scope)

• Confirm governance: owners, approval paths, and a written segmentation standard aligned to HICP Practice 9.3 ¹.
• Produce an initial device inventory focused on high-risk/high-criticality areas (ICU monitoring, imaging, infusion, lab).
• Draft a target segmentation diagram and identify required inter-zone dependencies (PACS, EHR interfaces, time/DNS/DHCP, management tools).
• Stand up an exception register for devices that cannot move immediately.

Day 31–60 (implement and prove)

• Create dedicated device segments for one or two priority categories and migrate devices with clinical sign-off.
• Implement firewall/ACL control points and build allowlist rules tied to documented workflows.
• Validate: run segmentation tests and capture results as evidence.
• Formalize third-party remote access patterns (bastion/jump host model, approvals, logging) and document them in third-party files.

Day 61–90 (expand and operationalize)

• Expand segmentation to additional device categories and sites using the same repeatable pattern.
• Start routine rule review and exception review.
• Add monitoring alerts for unexpected inter-zone traffic and document incident response runbooks for device network anomalies.
• Audit-pack assembly: diagrams, inventories, rule exports, tests, and change tickets in a single evidence folder for fast exams.

Frequently Asked Questions

Do all medical devices need their own VLAN?

No. The requirement is dedicated network segments with controlled access, not one VLAN per device. Group devices with similar risk and communication needs, then enforce strict controls between that segment and other zones ¹.

Can we meet the requirement with VLANs only?

VLANs help with separation, but auditors typically expect enforced control of traffic between zones. Put an actual policy enforcement point between device segments and clinical/administrative networks, and retain proof of the rules in place ¹.

What about devices that need to talk to cloud services?

Allow it explicitly and narrowly. Document the destinations and ports, route egress through controlled points, and monitor for unexpected outbound connections from the device segment.

How do we handle vendor remote support without violating isolation?

Terminate remote access into a controlled pathway (such as a jump host) and require approvals and logging for sessions. Avoid direct inbound access to device subnets and avoid shared credentials.

We can’t move certain legacy devices right now. What should compliance expect?

Track them in an exception register with a defined owner, compensating controls, and a remediation plan. Auditors accept constraints more readily when you can show you understand the exposure and are actively managing it.

What evidence is fastest to produce for an audit?

A current network segmentation diagram, an inventory mapped to segments, and firewall/ACL rule exports covering device boundaries. Add test results that show prohibited traffic is blocked.

Footnotes

1. HICP 2023 - 405(d) Health Industry Cybersecurity Practices